Literature DB >> 19230851

TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

Andrej Grkovich1, Aaron Armando, Oswald Quehenberger, Edward A Dennis.   

Abstract

Group IVA phospholipase A(2) (GIVA PLA(2)) catalyzes the release of arachidonic acid (AA) from the sn-2 position of glycerophospholipids. AA is then further metabolized into terminal signaling molecules including numerous prostaglandins. We have now demonstrated the involvement of phosphatidic acid phosphohydrolase 1 (PAP-1) and protein kinase C (PKC) in the Toll-like receptor-4 (TLR-4) activation of GIVA PLA(2). We also studied the effect of PAP-1 and PKC on Ca+2 induced and synergy enhanced GIVA PLA(2) activation. We observed that the AA release induced by exposure of RAW 264.7 macrophages to the TLR-4 specific agonist Kdo(2)-Lipid A is blocked by the PAP-1 inhibitors bromoenol lactone (BEL) and propranolol as well as the PKC inhibitor Ro 31-8220; however these inhibitors did not reduce AA release stimulated by Ca+2 influx induced by the P2X7 purinergic receptor agonist ATP. Additionally, stimulation of cells with diacylglycerol (DAG), the product of PAP-1 mediated hydrolysis, initiated AA release from unstimulated cells as well as restored normal AA release from cells treated with PAP-1 inhibitors. Finally, neither PAP-1 nor PKC inhibition reduced GIVA PLA(2) synergistic activation by stimulation with Kdo(2)-Lipid A and ATP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230851      PMCID: PMC2743746          DOI: 10.1016/j.bbalip.2009.02.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  52 in total

1.  Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis.

Authors:  J Balsinde; M A Balboa; E A Dennis
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

2.  A cytosolic phospholipase in human neutrophils that hydrolyzes arachidonoyl-containing phosphatidylcholine.

Authors:  F Alonso; P M Henson; C C Leslie
Journal:  Biochim Biophys Acta       Date:  1986-09-12

Review 3.  Signaling through phosphatidylcholine breakdown.

Authors:  J H Exton
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

4.  Differential regulation of phospholipase D and phospholipase A2 by protein kinase C in P388D1 macrophages.

Authors:  J Balsinde; M A Balboa; P A Insel; E A Dennis
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  Group IV cytosolic phospholipase A2 binds with high affinity and specificity to phosphatidylinositol 4,5-bisphosphate resulting in dramatic increases in activity.

Authors:  M Mosior; D A Six; E A Dennis
Journal:  J Biol Chem       Date:  1998-01-23       Impact factor: 5.157

6.  Regulation of phosphatidic acid phosphohydrolase by epidermal growth factor. Reduced association with the EGF receptor followed by increased association with protein kinase Cepsilon.

Authors:  Y Jiang; Z Lu; Q Zang; D A Foster
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

7.  Intracellular Ca2+, inositol 1,4,5-trisphosphate and additional signalling in the stimulation by platelet-activating factor of prostaglandin E2 formation in P388D1 macrophage-like cells.

Authors:  R Asmis; C Randriamampita; R Y Tsien; E A Dennis
Journal:  Biochem J       Date:  1994-03-15       Impact factor: 3.857

Review 8.  Phosphatidylcholine breakdown and signal transduction.

Authors:  J H Exton
Journal:  Biochim Biophys Acta       Date:  1994-04-14

9.  Solubilization and properties of Ca2+-dependent human platelet phospholipase A2.

Authors:  R M Kramer; G C Checani; A Deykin; C R Pritzker; D Deykin
Journal:  Biochim Biophys Acta       Date:  1986-10-03

10.  The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus.

Authors:  N Divecha; H Banfić; R F Irvine
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  9 in total

Review 1.  Neuroinflammatory pathways in binge alcohol-induced neuronal degeneration: oxidative stress cascade involving aquaporin, brain edema, and phospholipase A2 activation.

Authors:  Michael A Collins; Edward J Neafsey
Journal:  Neurotox Res       Date:  2011-09-17       Impact factor: 3.911

2.  Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.

Authors:  Sumitra Miriyala; Thangaiah Subramanian; Manikandan Panchatcharam; Hongmei Ren; Mark I McDermott; Manjula Sunkara; Tracy Drennan; Susan S Smyth; H Peter Spielmann; Andrew J Morris
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

3.  Significance of arachidonic acid in ocular infections and inflammation.

Authors:  Trivendra Tripathi; Hassan Alizadeh
Journal:  Inflamm Cell Signal       Date:  2014

4.  The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Authors:  Rossana Maffei; Jenny Bulgarelli; Stefania Fiorcari; Linda Bertoncelli; Silvia Martinelli; Carla Guarnotta; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Sara De Biasi; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Claudio Tripodo; Mario Luppi; Andrea Cossarizza; Roberto Marasca
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

Review 5.  Phosphatidic acid phosphohydrolase in the regulation of inflammatory signaling.

Authors:  Andrej Grkovich; Edward A Dennis
Journal:  Adv Enzyme Regul       Date:  2009

6.  Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

Authors:  Joan P Graves; J Alyce Bradbury; Artiom Gruzdev; Hong Li; Caroline Duval; Fred B Lih; Matthew L Edin; Darryl C Zeldin
Journal:  FASEB J       Date:  2019-11-05       Impact factor: 5.834

Review 7.  Interface of Phospholipase Activity, Immune Cell Function, and Atherosclerosis.

Authors:  Robert M Schilke; Cassidy M R Blackburn; Temitayo T Bamgbose; Matthew D Woolard
Journal:  Biomolecules       Date:  2020-10-15

Review 8.  Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.

Authors:  Tiago Mateus; Filipa Martins; Alexandra Nunes; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

Review 9.  Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders.

Authors:  Rezan Ashayeri Ahmadabad; Zahra Mirzaasgari; Ali Gorji; Maryam Khaleghi Ghadiri
Journal:  Int J Mol Sci       Date:  2021-06-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.